Impact of Angiogenesis Inhibition by Sunitinib on Tumor Distribution of Temozolomide

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-07-4544
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Inhibition of Tumor Angiogenesis by Oral Etoposide

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2010English

Correction: Article on Inhibition of NF- B by Temozolomide

Cancer Research
Cancer ResearchOncology
2009English

Inhibition of Tumor Endothelial ERK Activation, Angiogenesis, and Tumor Growth by Sorafenib (BAY43-9006)

American Journal of Pathology
Forensic MedicinePathology
2006English

Impact of Acetylsalicylic Acid on Tumor Angiogenesis and Lymphangiogenesis Through Inhibition of VEGF Signaling in a Murine Sarcoma Model

Oncology Reports
MedicineCancer ResearchOncology
2013English

Normal Wound Healing and Tumor Angiogenesis as a Game of Competitive Inhibition

PLoS ONE
Multidisciplinary
2016English

Inhibition of Angiogenesis by Erbstatin, an Inhibitor of Tyrosine Kinase.

Journal of Antibiotics
Drug DiscoveryPharmacology
1993English

Synergistic Inhibition of Angiogenesis by Artesunate and CaptoprilIn VitroandIn Vivo

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2013English

Beneficial Effects of Sunitinib on Tumor Microenvironment and Immunotherapy Targeting Death Receptor5

OncoImmunology
OncologyAllergyImmunology
2018English

Tumor Angiogenesis 2012

Journal of Oncology
Oncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy